Topical testosterone propionate in the therapy of vulvar dystrophies.
187 patients with atrophic, hypertrophic and mixed vulvar dystrophy were treated with 2% testosterone propionate ointment from 18 months to 7 years. Symptoms, macroscopic, and histologic picture were evaluated before and during treatment. About 75% of the patients achieved good and excellent symptom relief. Treatment efficacy differentiates according to the type of dystrophy, and in relation to the lesion's extension and the duration of symptoms, which consist mostly of pruritus. Side effects from therapy were negligible.
D000287:Administration, Topical; D000328:Adult; D000368:Aged; D002908:Chronic Disease; D005260:Female; D006801:Humans; D008875:Middle Aged; D013739:Testosterone / Q000008:administration & dosage*; D014845:Vulvar Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology
D013739:Testosterone